{"ticker": {"uuid": "a31b0dd1-0fcb-42c6-adc3-b9e126e87e2f", "symbol": "600276", "name": "Jiangsu Hengrui Pharmaceuticals Co.,Ltd", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Jiangsu Hengrui Pharmaceuticals' Contrast Agent Added to China's Essential Medicines List", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNRXpHSmxHTU0yNlZvNTlIUi03UjNncklNRWlKV3o5N2dHQ1BhNTc1NEZNVXpNSHQ1bEtuYVk1RjZIOEVlNzRnZ29aVTVVc1MwN1JOUkNTOVBXMmxVSTJObHN2WkFscDJhaGlPM3JLR2hwWlY3MnVVQjB6TmphQkpfTW1HMGNJbHE0TlhvZl90VWZXZTYtYTZpd1lpYmJaTm41eFlnTHktTFlJM3dhc1BWSHo3ZUdvUQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T02:16:01+00:00", "published_display": "13 Jul 2026 02:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jiangsu Hengrui Pharmaceuticals stock (CNE0000014X5): Bristol Myers $15.2B deal sparks rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQLVpPYXFOdk5qRkxuWlZPUThjZmZrams3cTd1bks1SVdTRTd1N29XSWNiNkZzRHlvVTFUUWpqNC1lUXo0OVVKSDh4UEZaemd3R1hJME1RZnZzXzJsNXh5NnNVSjVBY056bGZHeW9wTjhzZWphZ2UyUS1iMUw3anhsSXVGR0luVHVwU0hIM1ItcjFBQzN2aWtxNUpmNnA2OEo0RFhzTjJ0QVplQnZzbnJET3F3Z0kyLWhoZGg3dElTSjh6Yy1NemdqOA?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jiangsu Hengrui Pharmaceuticals stock (CNE0000014X5): Shares surge 13% on $15.2B BMS deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOd084dzZZTU1hbXl4WDJKTUxvNUZvODcxbjJkS3dKVXh3R3k0X3ZMdXdJZHgzWDhUaUlwT3ZYTzVJNE5ESGNacmRITUh3RW1JWFN0R2JJR0ZBUWJtQzlNVVY0LVgxWk5oakdrUGF4MW1UN1lvQlZEYVdEMFRCRlFrbUVrQlUtbThvSThTbTh5dlZDSzE1VGY3cWlOclFScG9VYnlGTGlQbjJqdHNCQ1BMdExHd0wtLU8tSW9iemRKMlE1TEk?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China's Hengrui, Bristol Myers Squibb sign collaboration, licensing deals", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQY1pZOFI3TllhVktyOXFkc253MjhXRHdheDNrM3E0d3hLTzJmMGVUQmVsbEJnMmNlRU5LOW42OUZjNlJUQUhkblQ3Wl9Lc1BpTEwwMWcwbXJoLS1obkVHcXNfQW4zUnpvdFVjdmZydmtlRmlnWWVnbUhRN3FXaTRkcWRONzJhcEdWbVoyYTBMRHVnQkZMUWs4ZU1pMXhHTUVaeUVpQWVWOThWNHNOMjdRcV9YTEZIU3pQTmVORWhB?oc=5", "source_name": "Reuters", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can a Chinese drugmaker become a big pharma company? Hengrui is testing the waters", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOSVBINkNXVDYtd05ybFRQR2hObDgwR1FWQU96Uk1NNDlGcmJqWm1SOHRZQ0I3MktnUGlqeXkyRlg4TFpfMzBWb2VKUTd3YnJjUkVpWFY0eXNUZGZLY0NQbXh3bVV5NG82V1QyN0xpNEIxTVREZnNfTVJYdGNBY2tSRmlVelQyLUh1QjVlZEREQVFZR09TdkxoWA?oc=5", "source_name": "Endpoints News", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citigroup's long position in H shares of Jiangsu Hengrui Pharmaceuticals increases to 5.21% on Jan 14 - HKEX", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPUjQ4TWFYY1VoLUlydlFabWNtQ3A4S3R6N3RQNHdpdUlQajRpenlHc3Zfc1FJZi1fTlBSZk5IRzlsdGQwOWhpSFVLWnBDUE5IUUxrZjF5ckZYcXRPNWxmNmpURU5XRy1rdUZvTWFVNGNvWUpYUmdCV1lCT2NpOENjc3ZhVHJPYUExMkRwYVJRTEFZTmVVdDVRM25WT2dvZkhfQ01vVi1JTlgtRm1pLWlLOW9CLUxyOXhKOE1fRlF2dW1VSmtvUFdJR1VXRUFfajdfN2V3eF83RlJIWGg0NkVzeTlVY0NNdEk?oc=5", "source_name": "marketscreener.com", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jiangsu Hengrui Pharmaceuticals Appoints New Senior Vice President", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQcExEX083a0JIaVJmRzhYb0FuekNjZFZoVGVXQ08tNjkxVG9nZVdIQ3hxaGZLWGhwWVhfRHcyZENPVDVVWVJtOXVZelVyM3BYZUZmVklRYnc5MFRhRXZWWml6M0lLWngtMzJyeDVjdzhiM2U1Z3M4OEJrdzA4N1ZiVkRseXVNQWhZVEZ2NDVNQUt0V2NIeV9jTTJrQTZEX1JvWng4cnNpelo2dkt2S0tyM1VYZW1HbDBkUGFVNXMydlo4MXB5RFlLdDY0cVRRN3UzTEd6VkhKaklWYkx2cDRiUW5B?oc=5", "source_name": "The Globe and Mail", "published_at": "2025-12-04T08:00:00+00:00", "published_display": "04 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s Hengrui gets boost from fifth drug-licensing deal of year", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQT0M5Y1FvN1BHNHRzT29FbnhLZVJhUWJiMUwtdm9pR0M2Ykt4cEFiQmt0UVlZeUFkWmk1bDNHQU1NcHJ6cmhBdGxJUGxpZWxqc0h2ZVZEcEFRNHpzQ3hjTTA2S2xpWW1uVkp5Y1I4cVNLRVhrQVY5dVc0OUVlYm5idXFqWDRwa0FJMTVkMF9rODFRZ3dwaGplOVpsaVg0WlVYc0FNQXlRV25mVU04ZDF1UzZoMkU5cGNtYktud3ln0gG-AUFVX3lxTE5ZOVB3bHdaYlVNbjFKVjltRnJBWUtjR2lSR1FhcXZSTDI2YnE3WkJENlNZT1J3TDE0Qmt1di0wMHJHUzVKa2JZNVFnWDRnNE5oTGZHLTQycHdCRXp4Sjltdkh0b3llMm5hdVYyVlprWEh4eTFFblVDTGxOeGhuVGZpT2ZtbW45X3pNX2pJR24tM2dPUW95ZTBST2tCblpkeFBoNU01T1Q4aE1DUERRdDhCendkMWxsZEdSamVabHc?oc=5", "source_name": "South China Morning Post", "published_at": "2025-09-25T07:00:00+00:00", "published_display": "25 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Braveheart licenses Hengrui's heart drug HRS-1893 in $1B deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNc1FiWWhJQVg1OVVxSXc0OVZOQjc5RmNvbklhYWZXdy04ZGFwWkRIcGZPdUV3RmhqRzdfUWV2dTBseVdkQVd6d1pNUlZ1X2FNRTg1N0REbU93U1dzRVZ5RVVhdkhrNE54aG4xZ1RJY0JlOVZabUpwbEJWU3dwdm9OYWJNbWI0T1V1eEhJcjd0WndOX0VQTHRqWE9MYlk1WlBkd0E?oc=5", "source_name": "BioWorld News", "published_at": "2025-09-05T07:00:00+00:00", "published_display": "05 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s Jiangsu Hengrui signs licensing deal with Braveheart Bio for heart drug", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2025-09-05T07:00:00+00:00", "published_display": "05 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fierce Pharma Asia\u2014GSK's massive Hengrui deal; Takeda's revenue drop; Celltrion's major US plant buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQMWxFZEMxVFhRMllSRWhKdzIyWkNVSlVpdG94cWhLODhLakpWeVJ3QWFNLUNPTjVqcTUyRXlOWXVMLWVGMkhVdzVlN1MyY2RCemwtM2ZMNkFqekVXcXJQVWFYWEJtMVdTMTVGSTVWazhIQ0pHUTlnekhWM1FERHVUUEpWNWo1dGxVUTVRTjk0Z3FPdmRHb3lHZ2doYmlPbFRldHpxR3IyalNYZHNXd2c?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-08-01T07:00:00+00:00", "published_display": "01 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hengrui Shares Jump on GSK Deal Worth Up To $12 Billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOY1cta19lTmdVSkppd3h2MjRpd3BNZW82M0VqMU5QUGtvckpzak5ydE9hVE5sZnBOOUJTejQ5QjZtUG45NFNvNU9Dd0ZkVnNXZmJFcDdNbW1nSXVNU1Y3S2xiSHpodHdlZDFNTHdoTXYtRXRLU2FDTWNwbVpTZG1oRl9pS2o3eHU5c2ZTd0l3cjdTSnhGRkFqZUVpLVNxQ3h1MnlVV1h5eGI?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GSK, China's Jiangsu Hengrui strike $500 million drug-development deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUGpsODM0QnE0alFCOUc1YVp5dm9pT1ZmN1ZFcGJWeFAwSzRTaGtJODlVaEJJZlVFMGpQVWtpYnZEMFhoQTZkNDJHRDZ5VVhUcHNZLXJxOGNMMjNobTRKUXpXdlBwV01MY1RaVE5abEFBbnB1WjRRbG1WZldmOUxxT19UNWNjdEdUTFBUOEtjUF82bW9nR29MNG5CVm9Ya1pFcEVfUF93ZzhXQTNrZTR4dHVKYlhKRXEycEtRaW1QS2JBWkcySC1BWVBpMi0zR0pXLW9uSFFn?oc=5", "source_name": "Reuters", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GSK to pay Hengrui US$12.5 billion for global rights to 12 drug projects", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jiangsu Hengrui jumps 25% in solid Hong Kong trading debut", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2025-05-23T07:00:00+00:00", "published_display": "23 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Top Chinese Drugmaker Hengrui Set to Begin Hong Kong Trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNc1dhZldSbUNQQWdIdFRpaHc3RzM1N2xVOE4xNFZXU2psOWN0aHJkYVU0a1h1ZGplaGI3SDVUd0VpMDlSUm45UkhTRTZIY053a0N1SzBvaEphODRFZXVsaGxZWTFQNW1wVjBwcFNmNk9yRzc3bHgwUDdKcUdpeWhGa2prVi1OdnpydGFJc1VXcVl5MDhiNWUyc1ByV0ZRaGRTVmRhN1NSQ2NtYXhVX1JKRA?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-05-23T07:00:00+00:00", "published_display": "23 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China's Jiangsu Hengrui to raise $1.27 billion in Hong Kong listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPcXhHLTNEY1VEQy1WLWg1NzJ4ZFRrVjdScDZMRUp4N1gtV1F4SmxrVXpHVVJZMXNfRGdhTGFDRTZXeXRHT3lnWFlBZ3BzWFFrV3BZSkxERmtXVDFVRDRxQjByclZxNHJ2Rk9lRC16QzV4eFVlZGZWMTR5TXR6UEYwc0Q5M01EQWVER0F0N3l5aFhMV2VaVXE0SGZyYWp4V1dMY0YxbUNhNFNwRzczLUszeVp0QlFtWE5ka3d4Z1BSMlpvMFdoU3owdTZBMW9MM0hvTFhXZ3U1NUJ5QQ?oc=5", "source_name": "Reuters", "published_at": "2025-05-21T07:00:00+00:00", "published_display": "21 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China pharma migration: Hengrui greenlighted for Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZ28ySzNCSWh5YXd0WC1lTldTUGJnaWdHM3pINzl5aDhRcUxqTVJJSzBIdnB5VDBUUlFOcW9jQUFhLVhQTTU0TjVxcEtoRUpjTU5hNXpkSkNfYVpiczYyemxTZDJQOTdkbUp2RTQ0UTdob0ZkREZtOVZzVkZVUHNMaTk3b193VHJ5U3pYSlJqb0dKMWttVms0YW5YeXVWejN2NmdBWQ?oc=5", "source_name": "BioWorld News", "published_at": "2025-04-29T07:00:00+00:00", "published_display": "29 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jiangsu Hengrui, a preferred China partner for U.S. biotech, hints at more deals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPRkxzaUpJTDg5VVpPbldjS1ZlSXkwQ25PNFdZSDVZdE9Yd3BxczZ3WWRaX1NPOER3QkltYm9mVFV3dXVkbVlqV0FSYV9CSlZSdUdBaUFlWVRiTU9Odkc2N1pDRjB1M1RkM3c2N05Xa21kdFRvcktqd1lFU0dUdjN4V3JCRFJFcmY3?oc=5", "source_name": "STAT", "published_at": "2025-01-16T08:00:00+00:00", "published_display": "16 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hengrui Pharmaceutical (600276.SH): SHR-2173 injection obtained drug clinical trial approval notice", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNZkpQTEF1c2tMMXdFUUxOQkxNYXpTNllMLXdrOURvZk1JbmNiNGhyLWd3OXJub3lRN1JqREdyLTdiaEZWQ3dkOTRnYTlNcDRZRldRaHJjY0JPcUdtUmVDcGNmaVFFdzRMNm9FT19PSU9ZVVQwdnE2MXctUEJkU0NTRHlra1JQanc5OVJRZFU0ZTRmcjFtUlJBOEk0RnQ5T1hYN1A4OU9hNDRiRkRiZFU5ZmswVEpmdE0?oc=5", "source_name": "Moomoo", "published_at": "2024-05-14T07:00:00+00:00", "published_display": "14 May 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Jiangsu Hengrui Pharmaceuticals' Contrast Agent Added to China's Essential Medicines List", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNRXpHSmxHTU0yNlZvNTlIUi03UjNncklNRWlKV3o5N2dHQ1BhNTc1NEZNVXpNSHQ1bEtuYVk1RjZIOEVlNzRnZ29aVTVVc1MwN1JOUkNTOVBXMmxVSTJObHN2WkFscDJhaGlPM3JLR2hwWlY3MnVVQjB6TmphQkpfTW1HMGNJbHE0TlhvZl90VWZXZTYtYTZpd1lpYmJaTm41eFlnTHktTFlJM3dhc1BWSHo3ZUdvUQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-13T02:16:01+00:00", "published_display": "13 Jul 2026 02:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jiangsu Hengrui Pharmaceuticals stock (CNE0000014X5): Bristol Myers $15.2B deal sparks rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQLVpPYXFOdk5qRkxuWlZPUThjZmZrams3cTd1bks1SVdTRTd1N29XSWNiNkZzRHlvVTFUUWpqNC1lUXo0OVVKSDh4UEZaemd3R1hJME1RZnZzXzJsNXh5NnNVSjVBY056bGZHeW9wTjhzZWphZ2UyUS1iMUw3anhsSXVGR0luVHVwU0hIM1ItcjFBQzN2aWtxNUpmNnA2OEo0RFhzTjJ0QVplQnZzbnJET3F3Z0kyLWhoZGg3dElTSjh6Yy1NemdqOA?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jiangsu Hengrui Pharmaceuticals stock (CNE0000014X5): Shares surge 13% on $15.2B BMS deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOd084dzZZTU1hbXl4WDJKTUxvNUZvODcxbjJkS3dKVXh3R3k0X3ZMdXdJZHgzWDhUaUlwT3ZYTzVJNE5ESGNacmRITUh3RW1JWFN0R2JJR0ZBUWJtQzlNVVY0LVgxWk5oakdrUGF4MW1UN1lvQlZEYVdEMFRCRlFrbUVrQlUtbThvSThTbTh5dlZDSzE1VGY3cWlOclFScG9VYnlGTGlQbjJqdHNCQ1BMdExHd0wtLU8tSW9iemRKMlE1TEk?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China's Hengrui, Bristol Myers Squibb sign collaboration, licensing deals", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQY1pZOFI3TllhVktyOXFkc253MjhXRHdheDNrM3E0d3hLTzJmMGVUQmVsbEJnMmNlRU5LOW42OUZjNlJUQUhkblQ3Wl9Lc1BpTEwwMWcwbXJoLS1obkVHcXNfQW4zUnpvdFVjdmZydmtlRmlnWWVnbUhRN3FXaTRkcWRONzJhcEdWbVoyYTBMRHVnQkZMUWs4ZU1pMXhHTUVaeUVpQWVWOThWNHNOMjdRcV9YTEZIU3pQTmVORWhB?oc=5", "source_name": "Reuters", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can a Chinese drugmaker become a big pharma company? Hengrui is testing the waters", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOSVBINkNXVDYtd05ybFRQR2hObDgwR1FWQU96Uk1NNDlGcmJqWm1SOHRZQ0I3MktnUGlqeXkyRlg4TFpfMzBWb2VKUTd3YnJjUkVpWFY0eXNUZGZLY0NQbXh3bVV5NG82V1QyN0xpNEIxTVREZnNfTVJYdGNBY2tSRmlVelQyLUh1QjVlZEREQVFZR09TdkxoWA?oc=5", "source_name": "Endpoints News", "published_at": "2026-01-28T08:00:00+00:00", "published_display": "28 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citigroup's long position in H shares of Jiangsu Hengrui Pharmaceuticals increases to 5.21% on Jan 14 - HKEX", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPUjQ4TWFYY1VoLUlydlFabWNtQ3A4S3R6N3RQNHdpdUlQajRpenlHc3Zfc1FJZi1fTlBSZk5IRzlsdGQwOWhpSFVLWnBDUE5IUUxrZjF5ckZYcXRPNWxmNmpURU5XRy1rdUZvTWFVNGNvWUpYUmdCV1lCT2NpOENjc3ZhVHJPYUExMkRwYVJRTEFZTmVVdDVRM25WT2dvZkhfQ01vVi1JTlgtRm1pLWlLOW9CLUxyOXhKOE1fRlF2dW1VSmtvUFdJR1VXRUFfajdfN2V3eF83RlJIWGg0NkVzeTlVY0NNdEk?oc=5", "source_name": "marketscreener.com", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jiangsu Hengrui Pharmaceuticals Appoints New Senior Vice President", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQcExEX083a0JIaVJmRzhYb0FuekNjZFZoVGVXQ08tNjkxVG9nZVdIQ3hxaGZLWGhwWVhfRHcyZENPVDVVWVJtOXVZelVyM3BYZUZmVklRYnc5MFRhRXZWWml6M0lLWngtMzJyeDVjdzhiM2U1Z3M4OEJrdzA4N1ZiVkRseXVNQWhZVEZ2NDVNQUt0V2NIeV9jTTJrQTZEX1JvWng4cnNpelo2dkt2S0tyM1VYZW1HbDBkUGFVNXMydlo4MXB5RFlLdDY0cVRRN3UzTEd6VkhKaklWYkx2cDRiUW5B?oc=5", "source_name": "The Globe and Mail", "published_at": "2025-12-04T08:00:00+00:00", "published_display": "04 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s Hengrui gets boost from fifth drug-licensing deal of year", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQT0M5Y1FvN1BHNHRzT29FbnhLZVJhUWJiMUwtdm9pR0M2Ykt4cEFiQmt0UVlZeUFkWmk1bDNHQU1NcHJ6cmhBdGxJUGxpZWxqc0h2ZVZEcEFRNHpzQ3hjTTA2S2xpWW1uVkp5Y1I4cVNLRVhrQVY5dVc0OUVlYm5idXFqWDRwa0FJMTVkMF9rODFRZ3dwaGplOVpsaVg0WlVYc0FNQXlRV25mVU04ZDF1UzZoMkU5cGNtYktud3ln0gG-AUFVX3lxTE5ZOVB3bHdaYlVNbjFKVjltRnJBWUtjR2lSR1FhcXZSTDI2YnE3WkJENlNZT1J3TDE0Qmt1di0wMHJHUzVKa2JZNVFnWDRnNE5oTGZHLTQycHdCRXp4Sjltdkh0b3llMm5hdVYyVlprWEh4eTFFblVDTGxOeGhuVGZpT2ZtbW45X3pNX2pJR24tM2dPUW95ZTBST2tCblpkeFBoNU01T1Q4aE1DUERRdDhCendkMWxsZEdSamVabHc?oc=5", "source_name": "South China Morning Post", "published_at": "2025-09-25T07:00:00+00:00", "published_display": "25 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Braveheart licenses Hengrui's heart drug HRS-1893 in $1B deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNc1FiWWhJQVg1OVVxSXc0OVZOQjc5RmNvbklhYWZXdy04ZGFwWkRIcGZPdUV3RmhqRzdfUWV2dTBseVdkQVd6d1pNUlZ1X2FNRTg1N0REbU93U1dzRVZ5RVVhdkhrNE54aG4xZ1RJY0JlOVZabUpwbEJWU3dwdm9OYWJNbWI0T1V1eEhJcjd0WndOX0VQTHRqWE9MYlk1WlBkd0E?oc=5", "source_name": "BioWorld News", "published_at": "2025-09-05T07:00:00+00:00", "published_display": "05 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s Jiangsu Hengrui signs licensing deal with Braveheart Bio for heart drug", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2025-09-05T07:00:00+00:00", "published_display": "05 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fierce Pharma Asia\u2014GSK's massive Hengrui deal; Takeda's revenue drop; Celltrion's major US plant buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQMWxFZEMxVFhRMllSRWhKdzIyWkNVSlVpdG94cWhLODhLakpWeVJ3QWFNLUNPTjVqcTUyRXlOWXVMLWVGMkhVdzVlN1MyY2RCemwtM2ZMNkFqekVXcXJQVWFYWEJtMVdTMTVGSTVWazhIQ0pHUTlnekhWM1FERHVUUEpWNWo1dGxVUTVRTjk0Z3FPdmRHb3lHZ2doYmlPbFRldHpxR3IyalNYZHNXd2c?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-08-01T07:00:00+00:00", "published_display": "01 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hengrui Shares Jump on GSK Deal Worth Up To $12 Billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOY1cta19lTmdVSkppd3h2MjRpd3BNZW82M0VqMU5QUGtvckpzak5ydE9hVE5sZnBOOUJTejQ5QjZtUG45NFNvNU9Dd0ZkVnNXZmJFcDdNbW1nSXVNU1Y3S2xiSHpodHdlZDFNTHdoTXYtRXRLU2FDTWNwbVpTZG1oRl9pS2o3eHU5c2ZTd0l3cjdTSnhGRkFqZUVpLVNxQ3h1MnlVV1h5eGI?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GSK, China's Jiangsu Hengrui strike $500 million drug-development deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUGpsODM0QnE0alFCOUc1YVp5dm9pT1ZmN1ZFcGJWeFAwSzRTaGtJODlVaEJJZlVFMGpQVWtpYnZEMFhoQTZkNDJHRDZ5VVhUcHNZLXJxOGNMMjNobTRKUXpXdlBwV01MY1RaVE5abEFBbnB1WjRRbG1WZldmOUxxT19UNWNjdEdUTFBUOEtjUF82bW9nR29MNG5CVm9Ya1pFcEVfUF93ZzhXQTNrZTR4dHVKYlhKRXEycEtRaW1QS2JBWkcySC1BWVBpMi0zR0pXLW9uSFFn?oc=5", "source_name": "Reuters", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GSK to pay Hengrui US$12.5 billion for global rights to 12 drug projects", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPeTU5NTRXSnFScTdXeHFRVEZBbjBNX3lkcUFZdzUzRnVKaHlLNUQzVDhCUWkteXBZX09oNzY2OEJHVm9rQ0tQV2gyVkMxaEEwalB6VUVhSnNuX2d3alRrN0dSbk5hMUpTMWoxdXBCZWlzdk1wYU5rRnozaWZkMjVTRmdMMG1iNUZLT1lmU0kzcFhfOHc0dHY5VE5seW41eUFqaDRUdTlScFhoM3dlSFFUaElfODZvLWtsUGthMtIBvAFBVV95cUxOeHBxUFRmbS12SGRFT0U5cGlxMUl3a3FCa212M2VhNi1iYTc1cTZ5ZTFyaTVwRGRyVHRKLW5RdmlORWtGS3B0aUdaRjgxdXRwSVZ0dC11TUEwSzAxQ0lzb1hSVnRwX1FnVWhuSVVILXFZdnlEcWp0Ulc2MXY2OTZ6bV9Yb2wySzBDOHZwRFd4a0pydmRrMGxxMzUyNmFUTkdjVjg5bjdrX1paRVRtNEY0N1dGM25RdU9RaWdvOA?oc=5", "source_name": "South China Morning Post", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jiangsu Hengrui jumps 25% in solid Hong Kong trading debut", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2025-05-23T07:00:00+00:00", "published_display": "23 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Top Chinese Drugmaker Hengrui Set to Begin Hong Kong Trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNc1dhZldSbUNQQWdIdFRpaHc3RzM1N2xVOE4xNFZXU2psOWN0aHJkYVU0a1h1ZGplaGI3SDVUd0VpMDlSUm45UkhTRTZIY053a0N1SzBvaEphODRFZXVsaGxZWTFQNW1wVjBwcFNmNk9yRzc3bHgwUDdKcUdpeWhGa2prVi1OdnpydGFJc1VXcVl5MDhiNWUyc1ByV0ZRaGRTVmRhN1NSQ2NtYXhVX1JKRA?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-05-23T07:00:00+00:00", "published_display": "23 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China's Jiangsu Hengrui to raise $1.27 billion in Hong Kong listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPcXhHLTNEY1VEQy1WLWg1NzJ4ZFRrVjdScDZMRUp4N1gtV1F4SmxrVXpHVVJZMXNfRGdhTGFDRTZXeXRHT3lnWFlBZ3BzWFFrV3BZSkxERmtXVDFVRDRxQjByclZxNHJ2Rk9lRC16QzV4eFVlZGZWMTR5TXR6UEYwc0Q5M01EQWVER0F0N3l5aFhMV2VaVXE0SGZyYWp4V1dMY0YxbUNhNFNwRzczLUszeVp0QlFtWE5ka3d4Z1BSMlpvMFdoU3owdTZBMW9MM0hvTFhXZ3U1NUJ5QQ?oc=5", "source_name": "Reuters", "published_at": "2025-05-21T07:00:00+00:00", "published_display": "21 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China pharma migration: Hengrui greenlighted for Hong Kong IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZ28ySzNCSWh5YXd0WC1lTldTUGJnaWdHM3pINzl5aDhRcUxqTVJJSzBIdnB5VDBUUlFOcW9jQUFhLVhQTTU0TjVxcEtoRUpjTU5hNXpkSkNfYVpiczYyemxTZDJQOTdkbUp2RTQ0UTdob0ZkREZtOVZzVkZVUHNMaTk3b193VHJ5U3pYSlJqb0dKMWttVms0YW5YeXVWejN2NmdBWQ?oc=5", "source_name": "BioWorld News", "published_at": "2025-04-29T07:00:00+00:00", "published_display": "29 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jiangsu Hengrui, a preferred China partner for U.S. biotech, hints at more deals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPRkxzaUpJTDg5VVpPbldjS1ZlSXkwQ25PNFdZSDVZdE9Yd3BxczZ3WWRaX1NPOER3QkltYm9mVFV3dXVkbVlqV0FSYV9CSlZSdUdBaUFlWVRiTU9Odkc2N1pDRjB1M1RkM3c2N05Xa21kdFRvcktqd1lFU0dUdjN4V3JCRFJFcmY3?oc=5", "source_name": "STAT", "published_at": "2025-01-16T08:00:00+00:00", "published_display": "16 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hengrui Pharmaceutical (600276.SH): SHR-2173 injection obtained drug clinical trial approval notice", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxNZkpQTEF1c2tMMXdFUUxOQkxNYXpTNllMLXdrOURvZk1JbmNiNGhyLWd3OXJub3lRN1JqREdyLTdiaEZWQ3dkOTRnYTlNcDRZRldRaHJjY0JPcUdtUmVDcGNmaVFFdzRMNm9FT19PSU9ZVVQwdnE2MXctUEJkU0NTRHlra1JQanc5OVJRZFU0ZTRmcjFtUlJBOEk0RnQ5T1hYN1A4OU9hNDRiRkRiZFU5ZmswVEpmdE0?oc=5", "source_name": "Moomoo", "published_at": "2024-05-14T07:00:00+00:00", "published_display": "14 May 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 61, "total_relevant": 20, "sentiment_summary": {"positive": 4, "negative": 0, "neutral": 16, "score": 53, "total": 20, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 7.1, "count": 11}, {"event": "deals", "label": "Deals and strategy", "weight": 4.55, "count": 7}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 53.19, "latest_week": "2026-07-17", "one_week_move": -4.6, "four_week_move": 9.9, "twelve_week_move": -4.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.484611, "market_dynamics_buy_signal": false, "relative_strength": -5.749694, "fair_value_gap": 6.7, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.6686, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.6% over one week, +9.9% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "South China Morning Post", "count": 4}, {"label": "Reuters", "count": 3}, {"label": "Moomoo", "count": 2}, {"label": "Ad-hoc-news.de", "count": 2}, {"label": "BioWorld News", "count": 2}, {"label": "Bloomberg.com", "count": 2}, {"label": "Endpoints News", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Deals and strategy", "count": 7}, {"label": "Earnings", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.6% over one week, +9.9% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Jiangsu Hengrui Pharmaceuticals' Contrast Agent Added to China's Essential Medicines List"}], "updated_at": "2026-07-23T08:48:41.816521+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}